a trend towards significancep = 0.051
There were significant interactions of pretreatment, MDMA dose and trial type (F(1,9) = 17.2, p = 0.003), as well as haloperidol and trial type (F(1,9) = 9.6, p = 0.01) and MDMA and trial type (F(1,9) = 8.2, p = 0.02), while there was a trend towards significance for a haloperidol and MDMA interaction (F(1,9) = 5.1, p = 0.051).